Phase 3 Acute Graft Versus Host Disease Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
Acute Graft Versus Host Disease
Anhui Provincial Hospital134 enrolled1 locationNCT07047456
Recruiting
Phase 3
Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy
Steroid-refractory Acute Graft Versus Host Disease
medac GmbH210 enrolled42 locationsNCT04629833
Recruiting
Phase 3
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
Acute Graft Versus Host Disease
Anhui Provincial Hospital198 enrolled6 locationsNCT06294691
Recruiting
Phase 3
Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD
Acute Graft Versus Host Disease
Peking University People's Hospital218 enrolled2 locationsNCT05921305
Recruiting
Phase 3
Use of Tocilizumab (TCZ) to prevent acute graft versus host disease (GVHD) randomized trial
Acute graft versus host disease (GVHD) post HLA-matched allogeneic haematopoietic progenitor cell transplantation (HPCT)
Royal Brisbane and Women's Hospital110 enrolled1 locationACTRN12614000266662